As a pharmacy student with interest in clinical research, I understand the importance to get the consent of the patients including not only the possible advantages but also the uncertainty of the risks. In this story, an AIDS patient with failure of three courses of therapy eagerly wanted to be enrolled in the CD-4 phase 1 clinical trial because of this patient’s strong belief that he would be healthy and cured after the novel treatment. I agreed with the principal investigator’s way which ruled out this patient’s enrollment in this study, by doing so, the researchers ensured the early phase
As a pharmacy student with interest in clinical research, I understand the importance to get the consent of the patients including not only the possible advantages but also the uncertainty of the risks. In this story, an AIDS patient with failure of three courses of therapy eagerly wanted to be enrolled in the CD-4 phase 1 clinical trial because of this patient’s strong belief that he would be healthy and cured after the novel treatment. I agreed with the principal investigator’s way which ruled out this patient’s enrollment in this study, by doing so, the researchers ensured the early phase